Friday, 9 May 2014
Topics
Meeting category
Date(s)
9 May 2014 - 10 May 2014
Location
Beijing,
China
Organizer
Asian Conference on Hepatitis and AIDS (ACHA) 2014
Related Enduring Materials
46
Enduring Materials
-
Opening Words
HBV Mini-symposium -
Harry Janssen, MD, PhD
What should we do to cure HBV
Erasmus MC, University Hospital Rotterdam, the Netherlands / Toronto Centre for Liver Disease, Canada
Some thoughts on strategies for reverting immune tolerance versus HBV infections
Yumei Wen, MD
Shanghai Medical school Fudan University, China
Cure for HBV - Correlates & Differences
Antiviral therapy of HBV/HCV in China from clinical perspective
Session 1: HIV -
HIV Cure
HIV co-infections from a European Perspective
HIV Clinical Implications
Rationale for starting therapy early
Update on HIV drug resistance
Treatment strategies in special populations (women, aging patients, late presenters)
Case Discussions
Satellite Symposium
Saturday, 10 May 2014
Session 2: HBV -
Has treating HBV reduced liver cancer incidence?
How does HBV cause cancer?
HBV Entry and Receptor General Discussion
Can chronic hepatitis B be cured? Evidence from clinical and basic studies
Session 3: HCV -
Innate immune responses to HCV Infection
Hepatitis C disease burden from Asian perspective
Abbvie Lunch Symposium
DAA’s Role in the USA
Donald Jensen, MD
RUSH University Medical Center, USA
DAA’s Role in Asia
IL-28B genotype, to detect or not to detect
Clinical management of hepatitis C patients: to treat or to wait
Managing HCV in HIV infected patients
Managing HCV in cirrhotic patients
Closing remark
Overview
Welcome
The 3rd Asian Conference on Hepatitis and AIDS - From Basic Science to Clinical Practice, was held in Beijing, China on 9 - 10 May 2014 at the Beijing University.
The Organizing Committee would like to thank all invited speakers and participants for their contribution to this conference!
We would like to thank our sponsor AbbVie (Platinum), Gilead (Supporter), the Chinese Society of Hepatology, CMA and the Chinese AIDS Society (Endorsers) for making this event possible.
The Executive Committee
Stephen Locarnini, BSc(Hons), PhD, MBBS, FRC(Path)
Victorian Infectious Diseases Reference Laboratory
General Information
Unique Features
- A program with a special focus on the needs in China and Asia
- A true scientific platform for local and regional clinicians and clinical researchers to present their data
- A unique opportunity for regional clinicians, researchers, and pharmaceutical companies to meet and collaborate
- A true scientific platform for local and regional clinicians and clinical researchers to present their data
- A unique opportunity for regional clinicians, researchers, and pharmaceutical companies to meet and collaborate
Meeting Objectives
This meeting aims to:
- Provide education on the latest treatment options for HBV, HCV, HIV and associated co-infections
- Present the latest research data, especially in the Asian context and translate knowledge into clinical practice
- Provide a platform for interaction and dialogue among different disciplines and facilitate collaborations among local, national and regional communities
- Provide education on the latest treatment options for HBV, HCV, HIV and associated co-infections
- Present the latest research data, especially in the Asian context and translate knowledge into clinical practice
- Provide a platform for interaction and dialogue among different disciplines and facilitate collaborations among local, national and regional communities
Learning Objectives
After participating in this activity, participants will be able to:
- Summarize the most recent results in drug development (including most recent clinical trial results) for HBV, HCV, and HIV
- Integrate the latest scientific results into daily clinical care to improve the treatment quality for HBV, HCV and HIV-positive individuals
- Summarize the most recent results in drug development (including most recent clinical trial results) for HBV, HCV, and HIV
- Integrate the latest scientific results into daily clinical care to improve the treatment quality for HBV, HCV and HIV-positive individuals
Practical Information
Disclaimer
This workshop is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this workshop, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this workshop. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the workshop.
Liability and insurance
By registering for the conference participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Support
Endorsers
Endorsers
Related Programs
